Probability of OS, LFS, NRM, relapse incidence (REL), and chronic GVHD-free, relapse-free survival (GFRS). OS, LFS, NRM, and REL of the overall cohort of patients included in the study (A). Cumulative incidence of NRM according to the type of donor employed (B). Five-year probability of LFS according to the type of donor employed (C). Five-year probability of GFRS according to the type of donor employed (D). All results were expressed as either probability or cumulative incidence (%) with 95% CI.